StockData
Danaher Corp logo

Danaher Corp

DHRNYSEIndustrial Instruments For Measurement, Display, and ControlFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 26, 2026Last filing: 10-Q on Jul 21, 2026Score 12/3027% above fair value
$232.23−4.75 (-2.00%)

Close on Oct 30, 2026Market cap $163.25BP/E 41.2Yield –

Danaher U.S. Industry Benchmark by Month

U.S. Industry Benchmark — U.S. Industry Total PMA Approvals

QuarterlyAnnualMonthly

Danaher U.S. Industry Benchmark: 187 in Sep 2026, down 7.0% from a year earlier.

Latest, Sep 2026
187
Period ended Sep 30, 2026
Change on a year earlier
-7.0%
201 in Sep 2025
History
141 months
Since Jan 2015
Sources
1
U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE)

Where the Sep 2026 figure comes from

Source: U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗

Reported in U.S. FDA openFDA Device PMA API.

Monthly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedU.S. Industry Benchmark — U.S. Industry Total PMA ApprovalsYear on yearSource
Sep 2026Sep 30, 2026187-7.0%U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Aug 2026Aug 31, 2026160-13.5%U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Jul 2026Jul 31, 2026218+9.5%U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Jun 2026Jun 30, 2026185-15.5%U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
May 2026May 31, 2026213+19.0%U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Apr 2026Apr 30, 2026210+10.5%U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Mar 2026Mar 31, 20261780.0%U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Feb 2026Feb 28, 2026253+29.1%U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Jan 2026Jan 31, 2026136-9.3%U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Dec 2025Dec 31, 2025218-9.5%U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Nov 2025Nov 30, 202580-63.0%U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Oct 2025Oct 31, 2025227+0.4%U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Sep 2025Sep 30, 2025201+14.9%U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Aug 2025Aug 31, 2025185+10.1%U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Jul 2025Jul 31, 2025199+2.1%U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Jun 2025Jun 30, 2025219+28.1%U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗

Cite this data

StockData. (2026). Danaher U.S. Industry Benchmark, monthly Jan 2015–Sep 2026 [Data set]. Compiled from Danaher SEC filings and investor materials. https://stockdatahq.com/stocks/dhr/kpis/ext-fda-pma-us-industry

See every metric in the Danaher KPI table. Data updated Nov 2, 2026.